Inappropriate use of potent topical glucocorticoids in infants

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 2, 2007, Pages 219-225

  Özön, Alev ^a   Cetinkaya, Semra ^a   Alikasifoglu, Ayfer ^a   Gonc, E Nazli ^a   Şen, Yaşar ^a   Kandemir, Nurgün ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adrenal insufficiency; Cushing's syndrome; Glucocorticoids; Iatrogenic disease; Liver steatosis; Obesity; Topical administration

Indexed keywords

CLOBETASOL PROPIONATE; CLOTRIMAZOLE; COTRIMOXAZOLE; GLUCOCORTICOID; HEXAMIDINE ISETIONATE; HYDROCORTISONE; IMAZOL; PREDNICARBATE; UNCLASSIFIED DRUG; ZINC OXIDE;

ADRENAL SUPPRESSION; ARTICLE; CASE REPORT; CUSHING SYNDROME; DIAPER DERMATITIS; DRUG SUBSTITUTION; DRUG USE; FEMALE; HUMAN; IATROGENIC DISEASE; INFANT; PRESCHOOL CHILD; SIDE EFFECT; SKIN DISEASE; SYSTEMIC THERAPY; TOPICAL TREATMENT; CHEMICALLY INDUCED DISORDER; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG EFFECT; FATTY LIVER; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; OBESITY; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CUSHING SYNDROME; DERMATITIS; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IATROGENIC DISEASE; INFANT; OBESITY; PITUITARY-ADRENAL SYSTEM;

EID: 34247118353     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.2.219     Document Type: Article

References (20)

1. Gonc EN, Kandemir N, Kinik ST. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood. Horm Res 2003; 60: 191-197.
2. Priftis K, Everard ML, Milner AD. Unexpected side-effects of inhaled steroids: a case report. Eur J Pediatr 1991; 150: 448-449.
3. Ozerdem U, Levi L, Song MK, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000; 130: 240-241.
4. Teelucksingh S, Bahall M, Coomansingh D, Suite M, Bartholomew C. Cushing's syndrome from topical glucocorticoids. West Indian Med J 1993; 42: 77-78.
5. Abma EM, Blanken R, de Heide LJM. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med 2003; 60: 148-150.
6. Stevens DJ. Cushing's syndrome due to the abuse of betamethasone nasal drops. J Laryngol Otol 1988; 102: 219-221.
7. Perry RJ, Findlay CA, Donaldson MDC. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child 2002; 87: 45-48.
8. Telucksingh S, Balkaran B, Ganeshmoorthi A, Arthur P. Proonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide. Ann Trop Pediatr 2002; 22: 89-91.
9. Steelman J, Kappy M. Adrenal suppression and growth retardation from ocular corticosteroids. J Pediatr Ophthalmol Strabismus 2001; 38: 177-178.
10. Turpeinen M, Salo OP, Leisti S. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986; 115: 475-484.
11. Patel L, Clayton PE, Addison GM, Price DA, David TJ. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995; 132: 950-955.
12. Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000; 105: 794-799.
13. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998; 83: 144-151.
14. Nathan AW, Rose GL. Fatal iatrogenic Cushing's syndrome. Lancet 1979; i: 207.
15. Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheum 1991; 9: 413-423.
16. Pan J, Ju D, Wang Q, Zhang M, Xia D, Zhang L, Yu H, Cao X. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett 2001; 76: 153-161.
17. Guven A, Karadeniz S, Aydin O, Akbalik M, Aydin M. Fatal disseminated cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid. Horm Res 2005; 64: 35-38.
18. Rogers PJ, Wood SM, Garrett EL, Krykant SP, Haddington NJ, Hayhurst J, Player GRH. Use of non-prescription topical steroids: patients' experiences. Br J Dermatol 2005; 152: 1193-1198.
19. Ermis B, Ors R, Tastekin A, Ozkan B. Cushing's syndrome secondary to topical corticosteroid abuse. Clin Endocrinol 2003; 58: 795-797.
20. Siklar Z, Bostanci I, Atli O, Dallar Y. An infantile Cushing syndrome due to misuse of topical steroid. Pediatr Dermatol 2004; 21: 561-563.